BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31989654)

  • 21. Naringenin and 17beta-estradiol coadministration prevents hormone-induced human cancer cell growth.
    Bulzomi P; Bolli A; Galluzzo P; Leone S; Acconcia F; Marino M
    IUBMB Life; 2010 Jan; 62(1):51-60. PubMed ID: 19960539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 17β-Estradiol-induced cell proliferation requires estrogen receptor (ER) α monoubiquitination.
    La Rosa P; Pesiri V; Marino M; Acconcia F
    Cell Signal; 2011 Jul; 23(7):1128-35. PubMed ID: 21356307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroglobin overexpression induced by the 17β-Estradiol-Estrogen receptor-α Pathway reduces the sensitivity of MCF-7 Breast cancer cell to paclitaxel.
    Fiocchetti M; Cipolletti M; Leone S; Ascenzi P; Marino M
    IUBMB Life; 2016 Aug; 68(8):645-51. PubMed ID: 27312786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamin II is required for 17β-estradiol signaling and autophagy-based ERα degradation.
    Totta P; Busonero C; Leone S; Marino M; Acconcia F
    Sci Rep; 2016 Mar; 6():23727. PubMed ID: 27009360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor.
    Grisouard J; Medunjanin S; Hermani A; Shukla A; Mayer D
    Mol Endocrinol; 2007 Oct; 21(10):2427-39. PubMed ID: 17609434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
    Boerner JL; Gibson MA; Fox EM; Posner ED; Parsons SJ; Silva CM; Shupnik MA
    Mol Endocrinol; 2005 Nov; 19(11):2660-70. PubMed ID: 15976008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters.
    Matthews J; Wihlén B; Tujague M; Wan J; Ström A; Gustafsson JA
    Mol Endocrinol; 2006 Mar; 20(3):534-43. PubMed ID: 16293641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
    Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
    Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
    Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta.
    van de Stolpe A; Slycke AJ; Reinders MO; Zomer AW; Goodenough S; Behl C; Seasholtz AF; van der Saag PT
    Mol Endocrinol; 2004 Dec; 18(12):2908-23. PubMed ID: 15345745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells.
    Zhou S; Turgeman G; Harris SE; Leitman DC; Komm BS; Bodine PV; Gazit D
    Mol Endocrinol; 2003 Jan; 17(1):56-66. PubMed ID: 12511606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 17β-Estradiol-induced interaction of ERα with NPPA regulates gene expression in cardiomyocytes.
    Mahmoodzadeh S; Pham TH; Kuehne A; Fielitz B; Dworatzek E; Kararigas G; Petrov G; Davidson MM; Regitz-Zagrosek V
    Cardiovasc Res; 2012 Dec; 96(3):411-21. PubMed ID: 22962310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estradiol induces type 8 17beta-hydroxysteroid dehydrogenase expression: crosstalk between estrogen receptor alpha and C/EBPbeta.
    Rotinen M; Celay J; Alonso MM; Arrazola A; Encio I; Villar J
    J Endocrinol; 2009 Jan; 200(1):85-92. PubMed ID: 18852215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naloxone acts as an antagonist of estrogen receptor activity in MCF-7 cells.
    Farooqui M; Geng ZH; Stephenson EJ; Zaveri N; Yee D; Gupta K
    Mol Cancer Ther; 2006 Mar; 5(3):611-20. PubMed ID: 16546975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutritional flavonoids modulate estrogen receptor alpha signaling.
    Virgili F; Acconcia F; Ambra R; Rinna A; Totta P; Marino M
    IUBMB Life; 2004 Mar; 56(3):145-51. PubMed ID: 15185748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH; Rowan BG
    Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
    Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
    BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sesterterpene MHO7 suppresses breast cancer cells as a novel estrogen receptor degrader.
    Zhao Y; Zhao C; Lu J; Wu J; Li C; Hu Z; Tian W; Yang L; Xiang J; Zhou H; Deng Z; Huang J; Hong K
    Pharmacol Res; 2019 Aug; 146():104294. PubMed ID: 31175940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.